China Geographic Atrophy Market: How Is Real-World Evidence Building for Treatment Decisions?
Real-world evidence for geographic atrophy treatment — the Chinese patient population characteristics, GA lesion progression rates, genetic factors, and treatment response patterns informing clinical practice and commercial market development — represents an important market intelligence dimension, with the China Geographic Atrophy Market reflecting RWE as a commercially valuable...
0 Comments 0 Shares 21 Views 0 Reviews